Kathrin Jansen to Antibodies, Bacterial
This is a "connection" page, showing publications Kathrin Jansen has written about Antibodies, Bacterial.
Connection Strength
0.723
-
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 2019 09 30; 37(42):6201-6207.
Score: 0.148
-
Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides. mSphere. 2018 08 08; 3(4).
Score: 0.137
-
Development and Validation of 13-plex Luminex-Based Assay for Measuring Human Serum Antibodies to Streptococcus pneumoniae Capsular Polysaccharides. mSphere. 2018 08 08; 3(4).
Score: 0.137
-
SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies. Vaccine. 2017 02 22; 35(8):1132-1139.
Score: 0.123
-
13-valent pneumococcal conjugate vaccine immune sera protects against pneumococcal serotype 1, 3, and 5 bacteremia in a neonatal rat challenge model. Hum Vaccin. 2011 Jan-Feb; 7 Suppl:75-84.
Score: 0.081
-
A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults. N Engl J Med. 2017 12 14; 377(24):2349-2362.
Score: 0.033
-
Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires. PLoS One. 2017; 12(9):e0183738.
Score: 0.032
-
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial. Vaccine. 2017 05 31; 35(24):3256-3263.
Score: 0.031